Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Theriva Biologics, Inc. (TOVX) had Weighted-Average Shares Outstanding (Diluted) of 12.14M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.51M |
|
-- |
|
-- |
|
$2.06M |
|
$-2.06M |
|
$0.07M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.00M |
|
$-2.06M |
|
$-2.04M |
|
12.14M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
12.14M |
$1.85 |
|
$1.85 |
|
| Balance Sheet Financials | |
$17.47M |
|
$0.22M |
|
$20.77M |
|
$38.24M |
|
$10.01M |
|
$1.67M |
|
$12.84M |
|
$22.86M |
|
$15.38M |
|
$15.38M |
|
$15.38M |
|
35.69M |
|
| Cash Flow Statement Financials | |
$-16.67M |
|
$-0.04M |
|
$18.19M |
|
$11.71M |
|
$13.10M |
|
$1.40M |
|
$0.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.74 |
|
-- |
|
-- |
|
0.10 |
|
0.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.98% |
|
-12.98% |
|
-5.22% |
|
-11.70% |
|
$0.43 |
|
$-1.38 |
|
$-1.37 |
|